{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T18:57:33Z","timestamp":1793213853830,"version":"4.5.0"},"reference-count":268,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,27]],"date-time":"2021-05-27T00:00:00Z","timestamp":1622073600000},"content-version":"am","delay-in-days":360,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","award":["DMR-1454754"],"award-info":[{"award-number":["DMR-1454754"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01GM123508"],"award-info":[{"award-number":["R01GM123508"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.bcp.2020.113931","type":"journal-article","created":{"date-parts":[[2020,3,26]],"date-time":"2020-03-26T20:01:41Z","timestamp":1585252901000},"page":"113931","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"special_numbering":"C","title":["The evolving landscape for cellular nitric oxide and hydrogen sulfide delivery systems: A new era of customized medications"],"prefix":"10.1016","volume":"176","author":[{"given":"Kearsley M.","family":"Dillon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan J.","family":"Carrazzone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John B.","family":"Matson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khosrow","family":"Kashfi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.bcp.2020.113931_b0005","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1523\/JNEUROSCI.16-03-01066.1996","article-title":"The possible role of hydrogen sulfide as an endogenous neuromodulator","volume":"16","author":"Abe","year":"1996","journal-title":"J. Neurosci."},{"issue":"13","key":"10.1016\/j.bcp.2020.113931_b0010","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1096\/fj.02-0211hyp","article-title":"Two\u2019s company, three's a crowd: can H2S be the third endogenous gaseous transmitter?","volume":"16","author":"Wang","year":"2002","journal-title":"FASEB J."},{"key":"10.1016\/j.bcp.2020.113931_b0015","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.bcp.2018.01.042","article-title":"The dichotomous role of H2S in cancer cell biology? Deja vu all over again","volume":"149","author":"Kashfi","year":"2018","journal-title":"Biochem. Pharmacol."},{"issue":"6471","key":"10.1016\/j.bcp.2020.113931_b0020","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/368502a0","article-title":"Stomach NO synthesis","volume":"368","author":"Benjamin","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2020.113931_b0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2020.113819","article-title":"Regulation of carbohydrate metabolism by nitric oxide and hydrogen sulfide: Implications in diabetes","author":"Gheibi","year":"2020","journal-title":"Biochem. Pharmacol."},{"issue":"29","key":"10.1016\/j.bcp.2020.113931_b0030","doi-asserted-by":"crossref","first-page":"21903","DOI":"10.1074\/jbc.R110.128363","article-title":"Redox biochemistry of hydrogen sulfide","volume":"285","author":"Kabil","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2020.113931_b0035","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1146\/annurev-pharmtox-010510-100505","article-title":"Hydrogen sulfide and cell signaling","volume":"51","author":"Li","year":"2011","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"issue":"1","key":"10.1016\/j.bcp.2020.113931_b0040","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.1471-4159.2010.06580.x","article-title":"Hydrogen sulfide as a gasotransmitter","volume":"113","author":"Gadalla","year":"2010","journal-title":"J. Neurochem."},{"issue":"29","key":"10.1016\/j.bcp.2020.113931_b0045","doi-asserted-by":"crossref","first-page":"29871","DOI":"10.1074\/jbc.R400005200","article-title":"Cystathionine \u03b2-Synthase: Structure, Function, Regulation, and Location of Homocystinuria-causing Mutations","volume":"279","author":"Miles","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.bcp.2020.113931_b0050","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1089\/ars.2011.4349","article-title":"Role of cystathionine \u03b3-lyase\/hydrogen sulfide pathway in cardiovascular disease: a novel therapeutic strategy?","volume":"17","author":"Pan","year":"2011","journal-title":"Antioxid. Redox Signal."},{"issue":"4","key":"10.1016\/j.bcp.2020.113931_b0055","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1089\/ars.2008.2253","article-title":"3-Mercaptopyruvate sulfurtransferase produces hydrogen sulfide and bound sulfane sulfur in the brain","volume":"11","author":"Shibuya","year":"2008","journal-title":"Antioxid. Redox Signal."},{"issue":"4","key":"10.1016\/j.bcp.2020.113931_b0060","doi-asserted-by":"crossref","first-page":"866","DOI":"10.3390\/microorganisms3040866","article-title":"Hydrogen sulfide in physiology and diseases of the digestive tract","volume":"3","author":"Singh","year":"2015","journal-title":"Microorganisms"},{"issue":"1","key":"10.1016\/j.bcp.2020.113931_b0065","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1089\/ars.2011.4349","article-title":"Role of cystathionine gamma-lyase\/hydrogen sulfide pathway in cardiovascular disease: a novel therapeutic strategy?","volume":"17","author":"Pan","year":"2012","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.bcp.2020.113931_b0070","series-title":"Chemistry, Biochemistry and Pharmacology of Hydrogen Sulfide","author":"Moore","year":"2015"},{"issue":"46","key":"10.1016\/j.bcp.2020.113931_b0075","doi-asserted-by":"crossref","first-page":"17977","DOI":"10.1073\/pnas.0705710104","article-title":"Hydrogen sulfide mediates the vasoactivity of garlic","volume":"104","author":"Benavides","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"2","key":"10.1016\/j.bcp.2020.113931_b0080","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1161\/01.RES.0000082524.34487.31","article-title":"Regulation of nitric oxide-sensitive guanylyl cyclase","volume":"93","author":"Friebe","year":"2003","journal-title":"Circ. Res."},{"key":"10.1016\/j.bcp.2020.113931_b0085","series-title":"Biochemistry of smooth muscle contraction","first-page":"257","article-title":"The nitric oxide-cyclic GMP signaling system","author":"Lincoln","year":"1996"},{"issue":"6","key":"10.1016\/j.bcp.2020.113931_b0090","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1111\/j.1538-7836.2010.03806.x","article-title":"Nitric oxide-sensitive guanylyl cyclase is the only nitric oxide receptor mediating platelet inhibition","volume":"8","author":"Dangel","year":"2010","journal-title":"J. Thrombosis Haemostasis: JTH"},{"issue":"6438","key":"10.1016\/j.bcp.2020.113931_b0095","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/364626a0","article-title":"A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds","volume":"364","author":"Lipton","year":"1993","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.bcp.2020.113931_b0100","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/0092-8674(94)90269-0","article-title":"Redox signaling: nitrosylation and related target interactions of nitric oxide","volume":"78","author":"Stamler","year":"1994","journal-title":"Cell"},{"issue":"5090","key":"10.1016\/j.bcp.2020.113931_b0105","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1126\/science.1281928","article-title":"Biochemistry of nitric oxide and its redox-activated forms","volume":"258","author":"Stamler","year":"1992","journal-title":"Science (New York, N.Y.)"},{"key":"10.1016\/j.bcp.2020.113931_b0110","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.redox.2015.08.009","article-title":"The dual role of iNOS in cancer","volume":"6","author":"Vannini","year":"2015","journal-title":"Redox Biol."},{"issue":"2","key":"10.1016\/j.bcp.2020.113931_b0115","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1038\/nrm1569","article-title":"Protein S-nitrosylation: purview and parameters","volume":"6","author":"Hess","year":"2005","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"10","key":"10.1016\/j.bcp.2020.113931_b0120","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1161\/01.RES.0000188210.72062.10","article-title":"Redox-dependent transcriptional regulation","volume":"97","author":"Liu","year":"2005","journal-title":"Circ. Res."},{"issue":"5","key":"10.1016\/j.bcp.2020.113931_b0125","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.bcp.2012.10.019","article-title":"Biology and therapeutic potential of hydrogen sulfide and hydrogen sulfide-releasing chimeras","volume":"85","author":"Kashfi","year":"2013","journal-title":"Biochem. Pharmacol."},{"issue":"21","key":"10.1016\/j.bcp.2020.113931_b0130","doi-asserted-by":"crossref","first-page":"6008","DOI":"10.1093\/emboj\/20.21.6008","article-title":"The vasorelaxant effect of H(2)S as a novel endogenous gaseous K(ATP) channel opener","volume":"20","author":"Zhao","year":"2001","journal-title":"EMBO J."},{"issue":"6","key":"10.1016\/j.bcp.2020.113931_b0135","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1124\/mol.105.017467","article-title":"Direct stimulation of K(ATP) channels by exogenous and endogenous hydrogen sulfide in vascular smooth muscle cells","volume":"68","author":"Tang","year":"2005","journal-title":"Mol. Pharmacol."},{"issue":"5","key":"10.1016\/j.bcp.2020.113931_b0140","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/nrd4433","article-title":"Hydrogen sulfide-based therapeutics: exploiting a unique but ubiquitous gasotransmitter","volume":"14","author":"Wallace","year":"2015","journal-title":"Nat. Rev. Drug Discov."},{"issue":"2","key":"10.1016\/j.bcp.2020.113931_b0145","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1097\/MNH.0b013e3283430651","article-title":"Signaling pathways for the vascular effects of hydrogen sulfide","volume":"20","author":"Wang","year":"2011","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"issue":"1","key":"10.1016\/j.bcp.2020.113931_b0150","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1089\/ars.2011.4359","article-title":"Modulation of ion channels by hydrogen sulfide","volume":"17","author":"Peers","year":"2012","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.bcp.2020.113931_b0155","unstructured":"N.L. Kanagy, C. Szabo, A. Papapetropoulos, Vascular Biology of Hydrogen Sulfide, Am. J. Physiol. Cell Physiol. (2017) ajpcell 00329 2016."},{"issue":"29","key":"10.1016\/j.bcp.2020.113931_b0160","doi-asserted-by":"crossref","first-page":"12016","DOI":"10.1021\/ja3009693","article-title":"Chemical characterization of the smallest S-nitrosothiol, HSNO; cellular cross-talk of H2S and S-nitrosothiols","volume":"134","author":"Filipovic","year":"2012","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.bcp.2020.113931_b0165","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1242\/jeb.128.1.139","article-title":"The sulphide-binding protein in the blood of the vestimentiferan tubeworm, Riftia pachyptila, is the extracellular hemoglobin","volume":"128","author":"Arp","year":"1987","journal-title":"J. Exp. Biol."},{"issue":"21","key":"10.1016\/j.bcp.2020.113931_b0170","doi-asserted-by":"crossref","first-page":"6092","DOI":"10.1016\/j.bmcl.2009.09.030","article-title":"Hydrogen sulfide induces nitric oxide release from nitrite","volume":"19","author":"Grossi","year":"2009","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"23","key":"10.1016\/j.bcp.2020.113931_b0175","doi-asserted-by":"crossref","first-page":"8801","DOI":"10.1073\/pnas.1206646109","article-title":"Shared signaling pathways among gasotransmitters","volume":"109","author":"Wang","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.bcp.2020.113931_b0180","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.niox.2014.05.014","article-title":"Hydrogen sulfide and nitric oxide interactions in inflammation","volume":"41","author":"Lo Faro","year":"2014","journal-title":"Nitric Oxide: Biol. Chem.\/Official J. Nitric Oxide Soc."},{"issue":"4","key":"10.1016\/j.bcp.2020.113931_b0185","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0162-0134(01)00335-X","article-title":"Characterization of NO binding to human cystathionine beta-synthase: possible implications of the effects of CO and NO binding to the human enzyme","volume":"87","author":"Taoka","year":"2001","journal-title":"J. Inorg. Biochem."},{"issue":"1\u20132","key":"10.1016\/j.bcp.2020.113931_b0190","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.tox.2006.12.023","article-title":"Direct inhibition of endothelial nitric oxide synthase by hydrogen sulfide: contribution to dual modulation of vascular tension","volume":"232","author":"Kubo","year":"2007","journal-title":"Toxicology"},{"issue":"1\u20132","key":"10.1016\/j.bcp.2020.113931_b0195","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.tox.2007.08.087","article-title":"Hydrogen sulfide inhibits activity of three isoforms of recombinant nitric oxide synthase","volume":"241","author":"Kubo","year":"2007","journal-title":"Toxicology"},{"issue":"2","key":"10.1016\/j.bcp.2020.113931_b0200","doi-asserted-by":"crossref","first-page":"H474","DOI":"10.1152\/ajpheart.00013.2002","article-title":"H(2)S-induced vasorelaxation and underlying cellular and molecular mechanisms","volume":"283","author":"Zhao","year":"2002","journal-title":"Am. J. Physiol. Heart Circulatory Physiol."},{"issue":"3","key":"10.1016\/j.bcp.2020.113931_b0205","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/j.bbrc.2006.05.002","article-title":"Hydrogen sulfide potentiates interleukin-1beta-induced nitric oxide production via enhancement of extracellular signal-regulated kinase activation in rat vascular smooth muscle cells","volume":"345","author":"Jeong","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bcp.2020.113931_b0210","doi-asserted-by":"crossref","first-page":"104","DOI":"10.3389\/fphys.2011.00104","article-title":"Hydrogen sulfide increases nitric oxide production from endothelial cells by an akt-dependent mechanism","volume":"2","author":"Predmore","year":"2011","journal-title":"Front. Physiol."},{"issue":"1\u20132","key":"10.1016\/j.bcp.2020.113931_b0215","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.ejps.2012.11.001","article-title":"Hydrogen sulfide increases nitric oxide production with calcium-dependent activation of endothelial nitric oxide synthase in endothelial cells","volume":"48","author":"Kida","year":"2013","journal-title":"Eur. J. Pharmaceutical Sci."},{"issue":"7","key":"10.1016\/j.bcp.2020.113931_b0220","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1111\/jcmm.12077","article-title":"Crosstalk between hydrogen sulfide and nitric oxide in endothelial cells","volume":"17","author":"Altaany","year":"2013","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.bcp.2020.113931_b0225","doi-asserted-by":"crossref","first-page":"45995","DOI":"10.1038\/srep45995","article-title":"Polysulfides (H2Sn) produced from the interaction of hydrogen sulfide (H2S) and nitric oxide (NO) activate TRPA1 channels","volume":"7","author":"Miyamoto","year":"2017","journal-title":"Sci. Rep."},{"issue":"9","key":"10.1016\/j.bcp.2020.113931_b0230","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.3181\/0712-RM-354","article-title":"Regulatory effects of hydrogen sulfide on IL-6, IL-8 and IL-10 levels in the plasma and pulmonary tissue of rats with acute lung injury","volume":"233","author":"Li","year":"2008","journal-title":"Exp. Biol. Med."},{"issue":"11","key":"10.1016\/j.bcp.2020.113931_b0235","doi-asserted-by":"crossref","first-page":"5210","DOI":"10.1021\/cr040650b","article-title":"Use of Lawesson\u2019s reagent in organic syntheses","volume":"107","author":"Ozturk","year":"2007","journal-title":"Chem. Rev."},{"issue":"9","key":"10.1016\/j.bcp.2020.113931_b0240","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1039\/C5MD00170F","article-title":"Investigating the generation of hydrogen sulfide from the phosphonamidodithioate slow-release donor GYY4137","volume":"6","author":"Alexander","year":"2015","journal-title":"MedChemComm"},{"issue":"20","key":"10.1016\/j.bcp.2020.113931_b0245","doi-asserted-by":"crossref","first-page":"6336","DOI":"10.1021\/jacs.6b01373","article-title":"pH-Controlled hydrogen sulfide release for myocardial ischemia-reperfusion injury","volume":"138","author":"Kang","year":"2016","journal-title":"J. Am. Chem. Soc."},{"issue":"6","key":"10.1016\/j.bcp.2020.113931_b0250","first-page":"796","article-title":"Hydrogen sulfide attenuates renin angiotensin and aldosterone pathological signaling to preserve kidney function and improve exercise tolerance in heart failure","volume":"3","author":"Li","year":"2018","journal-title":"JACC: Basic to Transl. Sci."},{"issue":"7","key":"10.1016\/j.bcp.2020.113931_b0255","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1021\/bc500150s","article-title":"Design and synthesis of polymeric hydrogen sulfide donors","volume":"25","author":"Hasegawa","year":"2014","journal-title":"Bioconjug. Chem."},{"issue":"6","key":"10.1016\/j.bcp.2020.113931_b0260","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1071\/CH09517","article-title":"Synthesis and preliminary pharmacological evaluation of aryl dithiolethiones with cyclooxygenase-2-selective inhibitory activity and hydrogen sulfide-releasing properties","volume":"63","author":"Zanatta","year":"2010","journal-title":"Aust. J. Chem."},{"issue":"1","key":"10.1016\/j.bcp.2020.113931_b0265","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1021\/ja1085723","article-title":"Cysteine-activated hydrogen sulfide (H2S) donors","volume":"133","author":"Zhao","year":"2011","journal-title":"J. Am. Chem. Soc."},{"issue":"4","key":"10.1016\/j.bcp.2020.113931_b0270","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1159\/000366339","article-title":"A novel controllable hydrogen sulfide-releasing molecule protects human skin keratinocytes against methylglyoxal-induced injury and dysfunction","volume":"34","author":"Yang","year":"2014","journal-title":"Cell. Physiol. Biochem."},{"issue":"18","key":"10.1016\/j.bcp.2020.113931_b0275","doi-asserted-by":"crossref","first-page":"7501","DOI":"10.1021\/acs.jmedchem.5b01033","article-title":"Design, synthesis, and cardioprotective effects of N-mercapto-based hydrogen sulfide donors","volume":"58","author":"Zhao","year":"2015","journal-title":"J. Med. Chem."},{"issue":"10","key":"10.1016\/j.bcp.2020.113931_b0280","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1021\/ml400239a","article-title":"Arylthioamides as H2S donors: l-cysteine-activated releasing properties and vascular effects in vitro and in vivo","volume":"4","author":"Martelli","year":"2013","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.bcp.2020.113931_b0285","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.phrs.2016.10.019","article-title":"ATB-346, a novel hydrogen sulfide-releasing anti-inflammatory drug, induces apoptosis of human melanoma cells and inhibits melanoma development in vivo","volume":"114","author":"De Cicco","year":"2016","journal-title":"Pharmacol. Res."},{"issue":"Supplement C","key":"10.1016\/j.bcp.2020.113931_b0290","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.niox.2014.04.006","article-title":"Enhanced chemopreventive effects of a hydrogen sulfide-releasing anti-inflammatory drug (ATB-346) in experimental colorectal cancer","volume":"41","author":"Elsheikh","year":"2014","journal-title":"Nitric Oxide"},{"issue":"6","key":"10.1016\/j.bcp.2020.113931_b0295","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1021\/ol500385a","article-title":"S-aroylthiooximes: a facile route to hydrogen sulfide releasing compounds with structure-dependent release kinetics","volume":"16","author":"Foster","year":"2014","journal-title":"Org. Lett."},{"issue":"11","key":"10.1016\/j.bcp.2020.113931_b0300","doi-asserted-by":"crossref","first-page":"2786","DOI":"10.1021\/ol401118k","article-title":"Light-induced hydrogen sulfide release from \u201ccaged\u201d gem-dithiols","volume":"15","author":"Devarie-Baez","year":"2013","journal-title":"Org. Lett."},{"issue":"47","key":"10.1016\/j.bcp.2020.113931_b0305","doi-asserted-by":"crossref","first-page":"11294","DOI":"10.1002\/chem.201701206","article-title":"Triggered and tunable hydrogen sulfide release from photogenerated thiobenzaldehydes","volume":"23","author":"Xiao","year":"2017","journal-title":"Chem. Eur. J."},{"issue":"25","key":"10.1016\/j.bcp.2020.113931_b0310","doi-asserted-by":"crossref","first-page":"3106","DOI":"10.1039\/C8CC01172A","article-title":"Light triggered uncaging of hydrogen sulfide (H2S) with real-time monitoring","volume":"54","author":"Venkatesh","year":"2018","journal-title":"Chem. Commun."},{"issue":"40","key":"10.1016\/j.bcp.2020.113931_b0315","doi-asserted-by":"crossref","first-page":"9059","DOI":"10.1039\/C9OB01502G","article-title":"A water soluble light activated hydrogen sulfide donor induced by an excited state meta effect","volume":"17","author":"Bera","year":"2019","journal-title":"Org. Biomol. Chem."},{"issue":"14","key":"10.1016\/j.bcp.2020.113931_b0320","doi-asserted-by":"crossref","first-page":"4514","DOI":"10.1002\/anie.201511244","article-title":"Esterase-sensitive prodrugs with tunable release rates and direct generation of hydrogen sulfide","volume":"55","author":"Zheng","year":"2016","journal-title":"Angew. Chem. Int. Ed. Engl."},{"issue":"26","key":"10.1016\/j.bcp.2020.113931_b0325","doi-asserted-by":"crossref","first-page":"9175","DOI":"10.1021\/ja00781a031","article-title":"Stereopopulation control. III. Facilitation of intramolecular conjugate addition of the carboxyl group","volume":"94","author":"Borchardt","year":"1972","journal-title":"J. Am. Chem. Soc."},{"issue":"7","key":"10.1016\/j.bcp.2020.113931_b0330","doi-asserted-by":"crossref","first-page":"4967","DOI":"10.1039\/C7SC00873B","article-title":"\u201cOn demand\u201d redox buffering by H2S contributes to antibiotic resistance revealed by a bacteria-specific H2S donor","volume":"8","author":"Shukla","year":"2017","journal-title":"Chem. Sci."},{"key":"10.1016\/j.bcp.2020.113931_b0335","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.addr.2018.07.007","article-title":"Tumor targeting via EPR: Strategies to enhance patient responses","volume":"130","author":"Golombek","year":"2018","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"35","key":"10.1016\/j.bcp.2020.113931_b0340","doi-asserted-by":"crossref","first-page":"4431","DOI":"10.1039\/C8PY00938D","article-title":"Recent advances in the delivery of hydrogen sulfide via a macromolecular approach","volume":"9","author":"Urquhart","year":"2018","journal-title":"Polym. Chem."},{"issue":"44","key":"10.1016\/j.bcp.2020.113931_b0345","doi-asserted-by":"crossref","first-page":"7122","DOI":"10.1039\/C8TB02352B","article-title":"The benefits of macromolecular hydrogen sulfide prodrugs","volume":"6","author":"Connal","year":"2018","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.bcp.2020.113931_b0350","article-title":"The benefits of macromolecular\/supramolecular approaches in H2S delivery: a review of polymeric and self-assembled H2S donors","author":"Kaur","year":"2019","journal-title":"Antioxid. Redox Signal."},{"issue":"3","key":"10.1016\/j.bcp.2020.113931_b0355","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/S0002-9629(15)40606-8","article-title":"Treatment of xerostomia with the bile secretion-stimulating drug anethole trithione: a clinical trial","volume":"318","author":"Hamada","year":"1999","journal-title":"Am. J. Med. Sci."},{"issue":"2","key":"10.1016\/j.bcp.2020.113931_b0360","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1039\/C4MD00373J","article-title":"Polymeric micelles for hydrogen sulfide delivery","volume":"6","author":"Hasegawa","year":"2015","journal-title":"MedChemComm"},{"issue":"15","key":"10.1016\/j.bcp.2020.113931_b0365","doi-asserted-by":"crossref","first-page":"5089","DOI":"10.1021\/ma501044b","article-title":"Functionalization of methacrylate polymers with thiooximes: a robust postpolymerization modification reaction and a method for the preparation of H2S-releasing polymers","volume":"47","author":"Foster","year":"2014","journal-title":"Macromolecules"},{"issue":"4","key":"10.1016\/j.bcp.2020.113931_b0370","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1021\/acs.molpharmaceut.6b01117","article-title":"H2S-releasing polymer micelles for studying selective cell toxicity","volume":"14","author":"Foster","year":"2017","journal-title":"Mol. Pharm."},{"issue":"3","key":"10.1016\/j.bcp.2020.113931_b0375","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1021\/acs.macromol.8b02315","article-title":"Tuning H2S release by controlling mobility in a micelle core","volume":"52","author":"Foster","year":"2019","journal-title":"Macromolecules"},{"issue":"1","key":"10.1016\/j.bcp.2020.113931_b0380","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1021\/acs.biomac.5b01469","article-title":"Macromolecular hydrogen sulfide donors trigger spatiotemporally confined changes in cell signaling","volume":"17","author":"Ercole","year":"2016","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.bcp.2020.113931_b0385","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.polymer.2019.02.004","article-title":"Photocontrollable water-soluble polymeric hydrogen sulfide (H2S) donor","volume":"168","author":"Li","year":"2019","journal-title":"Polymer"},{"issue":"40","key":"10.1016\/j.bcp.2020.113931_b0390","doi-asserted-by":"crossref","first-page":"7188","DOI":"10.1039\/C5PY01059D","article-title":"Long-term release of a thiobenzamide from a backbone functionalized poly(lactic acid)","volume":"6","author":"Long","year":"2015","journal-title":"Polym. Chem."},{"key":"10.1016\/j.bcp.2020.113931_b0395","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.actbio.2015.09.010","article-title":"Biological thiols-triggered hydrogen sulfide releasing microfibers for tissue engineering applications","volume":"27","author":"Feng","year":"2015","journal-title":"Acta Biomater."},{"issue":"41","key":"10.1016\/j.bcp.2020.113931_b0400","doi-asserted-by":"crossref","first-page":"27474","DOI":"10.1021\/acsami.6b06466","article-title":"Novel H2S releasing nanofibrous coating for in vivo dermal wound regeneration","volume":"8","author":"Wu","year":"2016","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"4","key":"10.1016\/j.bcp.2020.113931_b0405","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1039\/C8TB02566E","article-title":"pH and enzyme dual-responsive release of hydrogen sulfide for disc degeneration therapy","volume":"7","author":"Zheng","year":"2019","journal-title":"J. Mater. Chem. B"},{"issue":"66","key":"10.1016\/j.bcp.2020.113931_b0410","doi-asserted-by":"crossref","first-page":"13131","DOI":"10.1039\/C5CC04883D","article-title":"Peptide-based hydrogen sulphide-releasing gels","volume":"51","author":"Carter","year":"2015","journal-title":"Chem. Commun."},{"key":"10.1016\/j.bcp.2020.113931_b0415","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.actbio.2019.07.042","article-title":"Hydrogen sulfide-releasing peptide hydrogel limits the development of intimal hyperplasia in human vein segments","volume":"97","author":"Longchamp","year":"2019","journal-title":"Acta Biomater."},{"issue":"2","key":"10.1016\/j.bcp.2020.113931_b0420","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1021\/acs.biomac.8b01732","article-title":"Supramolecular tuning of H2S release from aromatic peptide amphiphile gels: effect of core unit substituents","volume":"20","author":"Qian","year":"2019","journal-title":"Biomacromolecules"},{"issue":"21","key":"10.1016\/j.bcp.2020.113931_b0425","doi-asserted-by":"crossref","first-page":"13363","DOI":"10.1021\/acs.joc.8b02151","article-title":"Hydrolytic decomposition of S-aroylthiooximes: Effect of pH and N-arylidene substitution on reaction rate","volume":"83","author":"Kaur","year":"2018","journal-title":"J. Org. Chem."},{"issue":"44","key":"10.1016\/j.bcp.2020.113931_b0430","doi-asserted-by":"crossref","first-page":"14945","DOI":"10.1021\/jacs.8b09320","article-title":"Self-assembled nanostructures regulate H2S release from constitutionally isomeric peptides","volume":"140","author":"Wang","year":"2018","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.bcp.2020.113931_b0435","doi-asserted-by":"crossref","first-page":"5093","DOI":"10.1021\/acsabm.9b00768","article-title":"Supramolecular nanostructures with tunable donor loading for controlled H2S release","volume":"2","author":"Wang","year":"2019","journal-title":"ACS Appl. Bio Mater."},{"key":"10.1016\/j.bcp.2020.113931_b0440","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1039\/C9CC08752D","article-title":"Elastase-triggered H2S delivery from polymer hydrogels","volume":"56","author":"Zhou","year":"2020","journal-title":"Chem. Commun."},{"issue":"24","key":"10.1016\/j.bcp.2020.113931_b0445","doi-asserted-by":"crossref","first-page":"9265","DOI":"10.1073\/pnas.84.24.9265","article-title":"Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide","volume":"84","author":"Ignarro","year":"1987","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"1","key":"10.1016\/j.bcp.2020.113931_b0450","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1161\/hh0102.102330","article-title":"Nitric oxide donors and cardiovascular agents modulating the bioactivity of nitric oxide: an overview","volume":"90","author":"Ignarro","year":"2002","journal-title":"Circ. Res."},{"issue":"1","key":"10.1016\/j.bcp.2020.113931_b0455","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1023\/A:1005940202801","article-title":"Molecular biology of nitric oxide synthases","volume":"17","author":"Geller","year":"1998","journal-title":"Cancer Metastasis Rev."},{"issue":"4","key":"10.1016\/j.bcp.2020.113931_b0460","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1093\/bja\/74.4.443","article-title":"Nitric oxide: an endogenous gas","volume":"74","author":"Quinn","year":"1995","journal-title":"Br. J. Anaesth."},{"issue":"10","key":"10.1016\/j.bcp.2020.113931_b0465","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1038\/ni1001-907","article-title":"Nitric oxide and the immune response","volume":"2","author":"Bogdan","year":"2001","journal-title":"Nat. Immunol."},{"issue":"3","key":"10.1016\/j.bcp.2020.113931_b0470","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/j.1745-7254.2005.00058.x","article-title":"Nitric oxide: a newly discovered function on wound healing","volume":"26","author":"Luo","year":"2005","journal-title":"Acta Pharmacol. Sin."},{"issue":"3","key":"10.1016\/j.bcp.2020.113931_b0475","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1517\/13543784.12.3.455","article-title":"The potential of nitric oxide therapeutics in stroke","volume":"12","author":"Willmot","year":"2003","journal-title":"Expert Opin. Invest. Drugs"},{"issue":"3","key":"10.1016\/j.bcp.2020.113931_b0480","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/nrd.2015.1","article-title":"Gasotransmitters in cancer: from pathophysiology to experimental therapy","volume":"15","author":"Szabo","year":"2016","journal-title":"Nat. Rev. Drug Discov."},{"issue":"8","key":"10.1016\/j.bcp.2020.113931_b0485","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1111\/bph.12369","article-title":"Regulation of mitochondrial bioenergetic function by hydrogen sulfide. Part I. Biochemical and physiological mechanisms","volume":"171","author":"Szabo","year":"2014","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bcp.2020.113931_b0490","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S1054-3589(08)57002-5","article-title":"Anti-inflammatory agents as cancer therapeutics","volume":"57","author":"Kashfi","year":"2009","journal-title":"Adv. Pharmacol."},{"key":"10.1016\/j.bcp.2020.113931_b0495","series-title":"Nitric Oxide Donors: Novel Biomedical Applications and Perspectives","first-page":"75","article-title":"Nitric oxide donors and therapeutic applications in cancer","author":"Kashfi","year":"2017"},{"key":"10.1016\/j.bcp.2020.113931_b0500","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.niox.2015.08.007","article-title":"Inhaled nitric oxide: current clinical concepts","volume":"50","author":"Bhatraju","year":"2015","journal-title":"Nitric Oxide"},{"issue":"2","key":"10.1016\/j.bcp.2020.113931_b0505","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1111\/j.1476-5381.1995.tb16670.x","article-title":"Inhibition of angiogenesis, tumour growth and metastasis by the NO-releasing vasodilators, isosorbide mononitrate and dinitrate","volume":"116","author":"Pipili-Synetos","year":"1995","journal-title":"Br. J. Pharmacol."},{"issue":"11","key":"10.1016\/j.bcp.2020.113931_b0510","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1093\/carcin\/17.11.2477","article-title":"Histogenesis and the role of p53 and K-ras mutations in hepatocarcinogenesis by glyceryl trinitrate (nitroglycerin) in male F344 rats","volume":"17","author":"Tamano","year":"1996","journal-title":"Carcinogenesis"},{"issue":"5","key":"10.1016\/j.bcp.2020.113931_b0515","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1016\/j.bmcl.2015.12.030","article-title":"Design and synthesis of novel hybrid sydnonimine and prodrug useful for glaucomatous optic neuropathy","volume":"26","author":"Acharya","year":"2016","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"4","key":"10.1016\/j.bcp.2020.113931_b0520","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1021\/cr000040l","article-title":"Nitric oxide donors: chemical activities and biological applications","volume":"102","author":"Wang","year":"2002","journal-title":"Chem. Rev."},{"issue":"23","key":"10.1016\/j.bcp.2020.113931_b0525","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1056\/NEJM199112053252301","article-title":"Aspirin use and reduced risk of fatal colon cancer","volume":"325","author":"Thun","year":"1991","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.bcp.2020.113931_b0530","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/S0016-5085(03)00887-4","article-title":"Daily soluble aspirin and prevention of colorectal adenoma recurrence: one-year results of the APACC trial","volume":"125","author":"Benamouzig","year":"2003","journal-title":"Gastroenterology"},{"issue":"9826","key":"10.1016\/j.bcp.2020.113931_b0535","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1016\/S0140-6736(11)61720-0","article-title":"Short-term effects of daily aspirin on cancer incidence, mortality, and non-vascular death: analysis of the time course of risks and benefits in 51 randomised controlled trials","volume":"379","author":"Rothwell","year":"2012","journal-title":"Lancet (London, England)"},{"issue":"5","key":"10.1016\/j.bcp.2020.113931_b0540","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/nrd794","article-title":"Potential cardioprotective actions of no-releasing aspirin","volume":"1","author":"Wallace","year":"2002","journal-title":"Nat. Rev. Drug Discov."},{"issue":"1","key":"10.1016\/j.bcp.2020.113931_b0545","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1046\/j.1472-8206.2003.00125.x","article-title":"The therapeutic potential of NO-NSAIDs","volume":"17","author":"Wallace","year":"2003","journal-title":"Fundam. Clin. Pharmacol."},{"issue":"2","key":"10.1016\/j.bcp.2020.113931_b0550","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1053\/gast.2000.9304","article-title":"Nitric oxide in mucosal defense: a little goes a long way","volume":"119","author":"Wallace","year":"2000","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.bcp.2020.113931_b0555","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1046\/j.1365-2036.1997.115286000.x","article-title":"NO-naproxen vs. naproxen: ulcerogenic, analgesic and anti-inflammatory effects","volume":"11","author":"Davies","year":"1997","journal-title":"Aliment. Pharmacol. Ther."},{"issue":"3","key":"10.1016\/j.bcp.2020.113931_b0560","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/0014-2999(94)90136-8","article-title":"A diclofenac derivative without ulcerogenic properties","volume":"257","author":"Wallace","year":"1994","journal-title":"Eur. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.bcp.2020.113931_b0565","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/0016-5085(94)90074-4","article-title":"Novel nonsteroidal anti-inflammatory drug derivatives with markedly reduced ulcerogenic properties in the rat","volume":"107","author":"Wallace","year":"1994","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.bcp.2020.113931_b0570","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/0016-5085(95)90341-0","article-title":"A nitric oxide-releasing nonsteroidal anti-inflammatory drug accelerates gastric ulcer healing in rats","volume":"109","author":"Elliott","year":"1995","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.bcp.2020.113931_b0575","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1248\/cpb.60.465","article-title":"NO-NSAIDs. Part 3: nitric oxide-releasing prodrugs of non-steroidal anti-inflammatory drugs","volume":"60","author":"Borhade","year":"2012","journal-title":"Chem. Pharm. Bull."},{"issue":"24","key":"10.1016\/j.bcp.2020.113931_b0580","doi-asserted-by":"crossref","first-page":"5587","DOI":"10.1016\/j.bmcl.2014.10.096","article-title":"Gastric-sparing nitric oxide-releasable 'true' prodrugs of aspirin and naproxen","volume":"24","author":"Gund","year":"2014","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"18","key":"10.1016\/j.bcp.2020.113931_b0585","doi-asserted-by":"crossref","first-page":"5297","DOI":"10.1016\/j.bmcl.2009.07.142","article-title":"NO-NSAIDs: gastric-sparing nitric oxide-releasable prodrugs of non-steroidal anti-inflammatory drugs","volume":"19","author":"Nemmani","year":"2009","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"4","key":"10.1016\/j.bcp.2020.113931_b0590","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s10787-010-0043-7","article-title":"Oral bioavailability, efficacy and gastric tolerability of P2026, a novel nitric oxide-releasing diclofenac in rat","volume":"18","author":"Pathan","year":"2010","journal-title":"Inflammopharmacology"},{"issue":"3","key":"10.1016\/j.bcp.2020.113931_b0595","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1053\/gast.2003.50096","article-title":"Gastrointestinal safety of NO-aspirin (NCX-4016) in healthy human volunteers: a proof of concept endoscopic study","volume":"124","author":"Fiorucci","year":"2003","journal-title":"Gastroenterology"},{"issue":"19","key":"10.1016\/j.bcp.2020.113931_b0600","doi-asserted-by":"crossref","first-page":"10937","DOI":"10.1073\/pnas.1933204100","article-title":"Interaction of a selective cyclooxygenase-2 inhibitor with aspirin and NO-releasing aspirin in the human gastric mucosa","volume":"100","author":"Fiorucci","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"3","key":"10.1016\/j.bcp.2020.113931_b0605","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1124\/jpet.102.042754","article-title":"Nitric oxide-donating nonsteroidal anti-inflammatory drugs inhibit the growth of various cultured human cancer cells: evidence of a tissue type-independent effect","volume":"303","author":"Kashfi","year":"2002","journal-title":"J. Pharmacol. Experimental Therapeutics"},{"issue":"3","key":"10.1016\/j.bcp.2020.113931_b0610","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1124\/jpet.104.075994","article-title":"Positional isomerism markedly affects the growth inhibition of colon cancer cells by nitric oxide-donating aspirin in vitro and in vivo","volume":"312","author":"Kashfi","year":"2005","journal-title":"J. Pharmacol. Experimental Therapeutics"},{"key":"10.1016\/j.bcp.2020.113931_b0615","first-page":"389","article-title":"Flurbiprofen benzyl nitrate (NBS-242) inhibits the growth of A-431 human epidermoid carcinoma cells and targets beta-catenin","volume":"7","author":"Nath","year":"2013","journal-title":"Drug Design, Development and Therapy"},{"issue":"5","key":"10.1016\/j.bcp.2020.113931_b0620","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1021\/jm020969t","article-title":"Antiinflammatory, gastrosparing, and antiplatelet properties of new NO-donor esters of aspirin","volume":"46","author":"Cena","year":"2003","journal-title":"J. Med. Chem."},{"issue":"1","key":"10.1016\/j.bcp.2020.113931_b0625","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1006\/bbrc.2000.3121","article-title":"A common pathway for nitric oxide release from NO-aspirin and glyceryl trinitrate","volume":"274","author":"Grosser","year":"2000","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"6","key":"10.1016\/j.bcp.2020.113931_b0630","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/S0731-7085(02)00147-4","article-title":"In vitro metabolism of a nitroderivative of acetylsalicylic acid (NCX4016) by rat liver: LC and LC-MS studies","volume":"29","author":"Carini","year":"2002","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"3","key":"10.1016\/j.bcp.2020.113931_b0635","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1124\/jpet.104.076190","article-title":"In vitro metabolism of nitric oxide-donating aspirin: the effect of positional isomerism","volume":"312","author":"Gao","year":"2005","journal-title":"J. Pharmacol. Experimental Therapeutics"},{"issue":"4","key":"10.1016\/j.bcp.2020.113931_b0640","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/sj.bjp.0706743","article-title":"Mechanism of action of novel NO-releasing furoxan derivatives of aspirin in human platelets","volume":"148","author":"Turnbull","year":"2006","journal-title":"Br. J. Pharmacol."},{"issue":"6","key":"10.1016\/j.bcp.2020.113931_b0645","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1021\/jm701104f","article-title":"Searching for new NO-donor aspirin-like molecules: a new class of nitrooxy-acyl derivatives of salicylic acid","volume":"51","author":"Lazzarato","year":"2008","journal-title":"J. Med. Chem."},{"issue":"8","key":"10.1016\/j.bcp.2020.113931_b0650","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1002\/art.23929","article-title":"Recommendations for use of selective and nonselective nonsteroidal antiinflammatory drugs: an American College of Rheumatology white paper","volume":"59","author":"Solomon","year":"2008","journal-title":"Arthritis Rheum."},{"issue":"5","key":"10.1016\/j.bcp.2020.113931_b0655","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1097\/FJC.0b013e318157f72d","article-title":"COX-2 inhibitors and cardiovascular risk","volume":"50","author":"Funk","year":"2007","journal-title":"J. Cardiovasc. Pharmacol."},{"issue":"7","key":"10.1016\/j.bcp.2020.113931_b0660","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.bcp.2005.05.004","article-title":"Non-COX-2 targets and cancer: expanding the molecular target repertoire of chemoprevention","volume":"70","author":"Kashfi","year":"2005","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bcp.2020.113931_b0665","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.phrs.2013.09.008","volume":"78","author":"Martelli","year":"2013","journal-title":"Pharmacol. Res."},{"issue":"4","key":"10.1016\/j.bcp.2020.113931_b0670","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1016\/j.bmcl.2010.01.014","article-title":"Celecoxib analogs possessing a N-(4-nitrooxybutyl)piperidin-4-yl or N-(4-nitrooxybutyl)-1,2,3,6-tetrahydropyridin-4-yl nitric oxide donor moiety: synthesis, biological evaluation and nitric oxide release studies","volume":"20","author":"Chowdhury","year":"2010","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"5","key":"10.1016\/j.bcp.2020.113931_b0675","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1002\/cbdv.200900421","article-title":"Nitrooxymethyl-substituted analogues of rofecoxib: synthesis and pharmacological characterization","volume":"7","author":"Boschi","year":"2010","journal-title":"Chem. Biodivers."},{"issue":"9","key":"10.1016\/j.bcp.2020.113931_b0680","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/j.freeradbiomed.2005.06.011","article-title":"Selective nitros(yl)ation induced in vivo by a nitric oxide-donating cyclooxygenase-2 inhibitor: a NObonomic analysis","volume":"39","author":"Dhawan","year":"2005","journal-title":"Free Radical Biol. Med."},{"issue":"16","key":"10.1016\/j.bcp.2020.113931_b0685","doi-asserted-by":"crossref","first-page":"3295","DOI":"10.1016\/j.bmcl.2015.05.059","article-title":"Novel (pyrazolyl)benzenesulfonamides with a nitric oxide-releasing moiety as selective cyclooxygenase-2 inhibitors","volume":"25","author":"Bechmann","year":"2015","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"13","key":"10.1016\/j.bcp.2020.113931_b0690","doi-asserted-by":"crossref","first-page":"6528","DOI":"10.1016\/j.bmc.2008.05.028","article-title":"Diazen-1-ium-1,2-diolated nitric oxide donor ester prodrugs of 1-(4-methanesulfonylphenyl)-5-aryl-1H-pyrazol-3-carboxylic acids: synthesis, nitric oxide release studies and anti-inflammatory activities","volume":"16","author":"Abdellatif","year":"2008","journal-title":"Bioorg. Med. Chem."},{"issue":"15","key":"10.1016\/j.bcp.2020.113931_b0695","doi-asserted-by":"crossref","first-page":"4544","DOI":"10.1016\/j.bmcl.2010.06.022","article-title":"Celecoxib prodrugs possessing a diazen-1-ium-1,2-diolate nitric oxide donor moiety: synthesis, biological evaluation and nitric oxide release studies","volume":"20","author":"Abdellatif","year":"2010","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bcp.2020.113931_b0700","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.freeradbiomed.2015.01.029","article-title":"Chemotherapeutic potential of diazeniumdiolate-based aspirin prodrugs in breast cancer","volume":"83","author":"Basudhar","year":"2015","journal-title":"Free Radical Biol. Med."},{"issue":"24","key":"10.1016\/j.bcp.2020.113931_b0705","doi-asserted-by":"crossref","first-page":"5787","DOI":"10.1016\/j.bmcl.2015.10.047","article-title":"Synthesis, cyclooxygenase inhibition, anti-inflammatory evaluation and ulcerogenic liability of novel triarylpyrazoline derivatives as selective COX-2 inhibitors","volume":"25","author":"Abdellatif","year":"2015","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bcp.2020.113931_b0710","first-page":"1","article-title":"Synthesis, cyclooxygenase inhibition and anti-inflammatory evaluation of new 1,3,5-triaryl-4,5-dihydro-1H-pyrazole derivatives possessing methanesulphonyl pharmacophore","author":"Abdellatif","year":"2016","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bcp.2020.113931_b0715","first-page":"1","article-title":"Synthesis, cyclooxygenase inhibition, anti-inflammatory evaluation and ulcerogenic liability of new 1,5-diarylpyrazole derivatives","author":"Abdellatif","year":"2016","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bcp.2020.113931_b0720","first-page":"1","article-title":"Synthesis, cyclooxygenase inhibition, anti-inflammatory evaluation and ulcerogenic liability of new 1-phenylpyrazolo[3,4-d]pyrimidine derivatives","author":"Bakr","year":"2016","journal-title":"J. Enzyme Inhib. Med. Chem."},{"issue":"2","key":"10.1016\/j.bcp.2020.113931_b0725","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.bmc.2013.12.008","article-title":"Enhancing the pharmacodynamic profile of a class of selective COX-2 inhibiting nitric oxide donors","volume":"22","author":"Biava","year":"2014","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bcp.2020.113931_b0730","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bioorg.2014.01.001","article-title":"Design, synthesis and pharmacological evaluation of novel pyrrolizine derivatives as potential anticancer agents","volume":"53","author":"Gouda","year":"2014","journal-title":"Bioorg. Chem."},{"issue":"11","key":"10.1016\/j.bcp.2020.113931_b0735","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1021\/cb200274r","article-title":"Fifty years of diazeniumdiolate research. From laboratory curiosity to broad-spectrum biomedical advances","volume":"6","author":"Keefer","year":"2011","journal-title":"ACS Chem. Biol."},{"issue":"6","key":"10.1016\/j.bcp.2020.113931_b0740","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1016\/j.bmc.2012.01.046","article-title":"Diazeniumdiolated carbamates: a novel class of nitric oxide donors","volume":"20","author":"Nandurdikar","year":"2012","journal-title":"Bioorg. Med. Chem."},{"issue":"1","key":"10.1016\/j.bcp.2020.113931_b0745","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1124\/jpet.300.1.18","article-title":"O(2)-Vinyl 1-(pyrrolidin-1-yl)diazen-1-ium-1,2-diolate protection against D-galactosamine\/endotoxin-induced hepatotoxicity in mice: genomic analysis using microarrays","volume":"300","author":"Liu","year":"2002","journal-title":"J. Pharmacol. Experimental Therapeutics"},{"issue":"7","key":"10.1016\/j.bcp.2020.113931_b0750","doi-asserted-by":"crossref","first-page":"798","DOI":"10.2174\/187152009789056949","article-title":"The nitric oxide prodrug JS-K and its structural analogues as cancer therapeutic agents","volume":"9","author":"Maciag","year":"2009","journal-title":"Anti-Cancer Agents Med. Chem."},{"issue":"1","key":"10.1016\/j.bcp.2020.113931_b0755","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1186\/s12885-017-3351-0","article-title":"JS-K, a nitric oxide pro-drug, regulates growth and apoptosis through the ubiquitin-proteasome pathway in prostate cancer cells","volume":"17","author":"Tan","year":"2017","journal-title":"BMC Cancer"},{"issue":"3","key":"10.1016\/j.bcp.2020.113931_b0760","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.3892\/ol.2016.5535","article-title":"JS-K promotes apoptosis by inducing ROS production in human prostate cancer cells","volume":"13","author":"Qiu","year":"2017","journal-title":"Oncol. Lett."},{"issue":"11","key":"10.1016\/j.bcp.2020.113931_b0765","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1016\/j.bcp.2010.08.011","article-title":"JS-K, a nitric oxide-releasing prodrug, modulates ss-catenin\/TCF signaling in leukemic Jurkat cells: evidence of an S-nitrosylated mechanism","volume":"80","author":"Nath","year":"2010","journal-title":"Biochem. Pharmacol."},{"issue":"46","key":"10.1016\/j.bcp.2020.113931_b0770","doi-asserted-by":"crossref","first-page":"16526","DOI":"10.1021\/ja106552p","article-title":"Dual mechanisms of HNO generation by a nitroxyl prodrug of the diazeniumdiolate (NONOate) class","volume":"132","author":"Andrei","year":"2010","journal-title":"J. Am. Chem. Soc."},{"issue":"8","key":"10.1016\/j.bcp.2020.113931_b0775","doi-asserted-by":"crossref","first-page":"3262","DOI":"10.1021\/ic101736e","article-title":"HNO and NO release from a primary amine-based diazeniumdiolate as a function of pH","volume":"50","author":"Salmon","year":"2011","journal-title":"Inorg. Chem."},{"issue":"11","key":"10.1016\/j.bcp.2020.113931_b0780","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1021\/jm00011a005","article-title":"Prodrugs of nitroxyl as potential aldehyde dehydrogenase inhibitors vis-a-vis vascular smooth muscle relaxants","volume":"38","author":"Nagasawa","year":"1995","journal-title":"J. Med. Chem."},{"issue":"9","key":"10.1016\/j.bcp.2020.113931_b0785","doi-asserted-by":"crossref","first-page":"5537","DOI":"10.1073\/pnas.0937302100","article-title":"Positive inotropic and lusitropic effects of HNO\/NO- in failing hearts: independence from beta-adrenergic signaling","volume":"100","author":"Paolocci","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"14","key":"10.1016\/j.bcp.2020.113931_b0790","doi-asserted-by":"crossref","first-page":"4767","DOI":"10.1016\/j.bmc.2007.05.009","article-title":"O2-acetoxymethyl-protected diazeniumdiolate-based NSAIDs (NONO-NSAIDs): synthesis, nitric oxide release, and biological evaluation studies","volume":"15","author":"Velazquez","year":"2007","journal-title":"Bioorg. Med. Chem."},{"issue":"8","key":"10.1016\/j.bcp.2020.113931_b0795","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1016\/j.freeradbiomed.2004.06.013","article-title":"Nitrates and NO release: contemporary aspects in biological and medicinal chemistry","volume":"37","author":"Thatcher","year":"2004","journal-title":"Free Radical Biol. Med."},{"issue":"12","key":"10.1016\/j.bcp.2020.113931_b0800","doi-asserted-by":"crossref","first-page":"4061","DOI":"10.1021\/jm050211k","article-title":"Novel nonsteroidal antiinflammatory drugs possessing a nitric oxide donor diazen-1-ium-1,2-diolate moiety: design, synthesis, biological evaluation, and nitric oxide release studies","volume":"48","author":"Velazquez","year":"2005","journal-title":"J. Med. Chem."},{"issue":"6","key":"10.1016\/j.bcp.2020.113931_b0805","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1021\/jm701450q","article-title":"Second-generation aspirin and indomethacin prodrugs possessing an O(2)-(acetoxymethyl)-1-(2-carboxypyrrolidin-1-yl)diazenium-1,2-diolate nitric oxide donor moiety: design, synthesis, biological evaluation, and nitric oxide release studies","volume":"51","author":"Velazquez","year":"2008","journal-title":"J. Med. Chem."},{"issue":"18","key":"10.1016\/j.bcp.2020.113931_b0810","doi-asserted-by":"crossref","first-page":"10463","DOI":"10.1073\/pnas.181191198","article-title":"Nitroxyl anion exerts redox-sensitive positive cardiac inotropy in vivo by calcitonin gene-related peptide signaling","volume":"98","author":"Paolocci","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"8","key":"10.1016\/j.bcp.2020.113931_b0815","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1002\/ijc.23305","article-title":"Nitroxyl inhibits breast tumor growth and angiogenesis","volume":"122","author":"Norris","year":"2008","journal-title":"Int. J. Cancer"},{"issue":"20","key":"10.1016\/j.bcp.2020.113931_b0820","doi-asserted-by":"crossref","first-page":"7804","DOI":"10.1021\/jm400196q","article-title":"Synthesis and chemical and biological comparison of nitroxyl- and nitric oxide-releasing diazeniumdiolate-based aspirin derivatives","volume":"56","author":"Basudhar","year":"2013","journal-title":"J. Med. Chem."},{"issue":"3","key":"10.1016\/j.bcp.2020.113931_b0825","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1615\/ForumImmunDisTher.v1.i3.30","article-title":"Broad-spectrum anti-cancer activity of O-arylated diazeniumdiolates","volume":"1","author":"Keefer","year":"2010","journal-title":"Forum on Immunopathological Diseases and Therapeutics"},{"key":"10.1016\/j.bcp.2020.113931_b0830","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/1471-2407-12-130","article-title":"JS-K, a glutathione\/glutathione S-transferase-activated nitric oxide releasing prodrug inhibits androgen receptor and WNT-signaling in prostate cancer cells","volume":"12","author":"Laschak","year":"2012","journal-title":"BMC Cancer"},{"issue":"5","key":"10.1016\/j.bcp.2020.113931_b0835","first-page":"887","article-title":"Class pi glutathione S-transferase: Meisenheimer complex formation","volume":"33","author":"Bico","year":"1994","journal-title":"Biochem. Mol. Biol. Int."},{"issue":"4","key":"10.1016\/j.bcp.2020.113931_b0840","first-page":"409","article-title":"JS-K, a glutathione\/glutathione S-transferase-activated nitric oxide donor of the diazeniumdiolate class with potent antineoplastic activity","volume":"2","author":"Shami","year":"2003","journal-title":"Mol. Cancer Ther."},{"issue":"11","key":"10.1016\/j.bcp.2020.113931_b0845","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1016\/j.leukres.2009.01.002","article-title":"JS-K, an arylating nitric oxide (NO) donor, has synergistic anti-leukemic activity with cytarabine (ARA-C)","volume":"33","author":"Shami","year":"2009","journal-title":"Leuk. Res."},{"issue":"3","key":"10.1016\/j.bcp.2020.113931_b0850","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1002\/jcp.10380","article-title":"JS-K, a novel non-ionic diazeniumdiolate derivative, inhibits Hep 3B hepatoma cell growth and induces c-Jun phosphorylation via multiple MAP kinase pathways","volume":"197","author":"Ren","year":"2003","journal-title":"J. Cell. Physiol."},{"issue":"2","key":"10.1016\/j.bcp.2020.113931_b0855","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1227\/NEU.0b013e31823209cf","article-title":"JS-K, a glutathione S-transferase-activated nitric oxide donor with antineoplastic activity in malignant gliomas","volume":"70","author":"Weyerbrock","year":"2012","journal-title":"Neurosurgery"},{"issue":"5","key":"10.1016\/j.bcp.2020.113931_b0860","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1124\/mol.65.5.1070","article-title":"Tumor cell responses to a novel glutathione S-transferase-activated nitric oxide-releasing prodrug","volume":"65","author":"Findlay","year":"2004","journal-title":"Mol. Pharmacol."},{"issue":"3","key":"10.1016\/j.bcp.2020.113931_b0865","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1021\/jm050700k","article-title":"PABA\/NO as an anticancer lead: analogue synthesis, structure revision, solution chemistry, reactivity toward glutathione, and in vitro activity","volume":"49","author":"Saavedra","year":"2006","journal-title":"J. Med. Chem."},{"issue":"5","key":"10.1016\/j.bcp.2020.113931_b0870","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1002\/ijc.26106","article-title":"Growth-inhibitory and chemosensitizing effects of the glutathione-S-transferase-pi-activated nitric oxide donor PABA\/NO in malignant gliomas","volume":"130","author":"Kogias","year":"2012","journal-title":"Int. J. Cancer"},{"issue":"11","key":"10.1016\/j.bcp.2020.113931_b0875","doi-asserted-by":"crossref","first-page":"4641","DOI":"10.1021\/jm400393u","article-title":"Hybrid molecule from O2-(2,4-dinitrophenyl)diazeniumdiolate and oleanolic acid: a glutathione S-transferase pi-activated nitric oxide prodrug with selective anti-human hepatocellular carcinoma activity and improved stability","volume":"56","author":"Fu","year":"2013","journal-title":"J. Med. Chem."},{"issue":"2","key":"10.1016\/j.bcp.2020.113931_b0880","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0378-4274(98)00009-5","article-title":"Protection against carbon tetrachloride hepatotoxicity by oleanolic acid is not mediated through metallothionein","volume":"95","author":"Liu","year":"1998","journal-title":"Toxicol. Lett."},{"issue":"30","key":"10.1016\/j.bcp.2020.113931_b0885","doi-asserted-by":"crossref","first-page":"3427","DOI":"10.2217\/fon-2019-0317","article-title":"REPLATINUM Phase III randomized study: RRx-001 + platinum doublet versus platinum doublet in third-line small cell lung cancer","volume":"15","author":"Oronsky","year":"2019","journal-title":"Future Oncol."},{"issue":"3","key":"10.1016\/j.bcp.2020.113931_b0890","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/s41416-019-0504-8","article-title":"RRx-001 followed by platinum plus etoposide in patients with previously treated small-cell lung cancer","volume":"121","author":"Morgensztern","year":"2019","journal-title":"Br. J. Cancer"},{"issue":"4","key":"10.1016\/j.bcp.2020.113931_b0895","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.tranon.2018.12.001","article-title":"RRx-001 acts as a dual small molecule checkpoint inhibitor by downregulating CD47 on cancer cells and SIRP-alpha on monocytes\/macrophages","volume":"12","author":"Cabrales","year":"2019","journal-title":"Transl. Oncol."},{"issue":"1\u20133","key":"10.1016\/j.bcp.2020.113931_b0900","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jhazmat.2004.06.002","article-title":"1,3,3-Trinitroazetidine (TNAZ), a melt-cast explosive: synthesis, characterization and thermal behaviour","volume":"113","author":"Sikder","year":"2004","journal-title":"J. Hazard. Mater."},{"key":"10.1016\/j.bcp.2020.113931_b0905","unstructured":"S.J. Knox, L. Cannizzo, K. Warner, R. Wardle, S. Velarde, S. Ning, Cyclic nitro compounds, pharmaceutical compositions thereof and uses thereof., RadioRx, Inc., Alliant Techsystems Inc., United States, 2009."},{"key":"10.1016\/j.bcp.2020.113931_b0910","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.freeradbiomed.2012.11.003","article-title":"Antioxidant functions for the hemoglobin beta93 cysteine residue in erythrocytes and in the vascular compartment in vivo","volume":"55","author":"Vitturi","year":"2013","journal-title":"Free Radical Biol. Med."},{"issue":"7","key":"10.1016\/j.bcp.2020.113931_b0915","doi-asserted-by":"crossref","first-page":"947","DOI":"10.4155\/bio.13.331","article-title":"Development of methods for the bioanalysis of RRx-001 and metabolites","volume":"6","author":"Scicinski","year":"2014","journal-title":"Bioanalysis"},{"issue":"9","key":"10.1016\/j.bcp.2020.113931_b0920","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1124\/dmd.112.046755","article-title":"Preclinical evaluation of the metabolism and disposition of RRx-001, a novel investigative anticancer agent","volume":"40","author":"Scicinski","year":"2012","journal-title":"Drug Metab. Dispos.: Biol. Fate Chem."},{"issue":"25","key":"10.1016\/j.bcp.2020.113931_b0925","doi-asserted-by":"crossref","first-page":"21547","DOI":"10.18632\/oncotarget.4249","article-title":"Nrf2 activity as a potential biomarker for the pan-epigenetic anticancer agent, RRx-001","volume":"6","author":"Ning","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.bcp.2020.113931_b0930","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.redox.2015.07.002","article-title":"NO to cancer: The complex and multifaceted role of nitric oxide and the epigenetic nitric oxide donor, RRx-001","volume":"6","author":"Scicinski","year":"2015","journal-title":"Redox Biol."},{"key":"10.1016\/j.bcp.2020.113931_b0935","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.niox.2013.01.002","article-title":"Nitric oxide-mediated activity in anti-cancer photodynamic therapy","volume":"30","author":"Rapozzi","year":"2013","journal-title":"Nitric Oxide"},{"issue":"1","key":"10.1016\/j.bcp.2020.113931_b0940","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1089\/104454702753474931","article-title":"An update on photodynamic therapy applications","volume":"20","author":"Dougherty","year":"2002","journal-title":"J. Clin. Laser Med. Surg."},{"issue":"4","key":"10.1016\/j.bcp.2020.113931_b0945","first-page":"250","article-title":"Photodynamic therapy of cancer: an update","volume":"61","author":"Agostinis","year":"2011","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.bcp.2020.113931_b0950","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.redox.2015.07.015","article-title":"Dual roles of nitric oxide in the regulation of tumor cell response and resistance to photodynamic therapy","volume":"6","author":"Rapozzi","year":"2015","journal-title":"Redox Biol."},{"issue":"1\u20132","key":"10.1016\/j.bcp.2020.113931_b0955","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1615\/JEnvironPatholToxicolOncol.v25.i1-2.20","article-title":"Biophysical aspects of photodynamic therapy","volume":"25","author":"Juzeniene","year":"2006","journal-title":"J. Environ. Pathol. Toxicol. Oncol."},{"issue":"11","key":"10.1016\/j.bcp.2020.113931_b0960","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1054\/bjoc.2000.1157","article-title":"Nitric oxide production by tumour tissue: impact on the response to photodynamic therapy","volume":"82","author":"Korbelik","year":"2000","journal-title":"Br. J. Cancer"},{"issue":"3","key":"10.1016\/j.bcp.2020.113931_b0965","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jphotobiol.2009.02.005","article-title":"Is nitric oxide important in photodynamic therapy?","volume":"95","author":"Reeves","year":"2009","journal-title":"J. Photochem. Photobiol., B"},{"issue":"9","key":"10.1016\/j.bcp.2020.113931_b0970","first-page":"1785","article-title":"Involvement of nitric oxide during phthalocyanine (Pc4) photodynamic therapy-mediated apoptosis","volume":"58","author":"Gupta","year":"1998","journal-title":"Cancer Res."},{"issue":"5","key":"10.1016\/j.bcp.2020.113931_b0975","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1002\/lsm.22807","article-title":"Upregulation of nitric oxide in tumor cells as a negative adaptation to photodynamic therapy","volume":"50","author":"Girotti","year":"2018","journal-title":"Lasers Surg. Med."},{"key":"10.1016\/j.bcp.2020.113931_b0980","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.niox.2013.02.001","article-title":"Photochemical delivery of nitric oxide","volume":"34","author":"Ford","year":"2013","journal-title":"Nitric Oxide"},{"issue":"1","key":"10.1016\/j.bcp.2020.113931_b0985","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1039\/C9SC04039K","article-title":"Light-triggered nitric oxide (NO) release from photoresponsive polymersomes for corneal wound healing","volume":"11","author":"Duan","year":"2020","journal-title":"Chem. Sci."},{"issue":"15","key":"10.1016\/j.bcp.2020.113931_b0990","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20153735","article-title":"Contact lenses delivering nitric oxide under daylight for reduction of bacterial contamination","volume":"20","author":"Seggio","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bcp.2020.113931_b0995","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.pdpdt.2018.09.009","article-title":"Photodynamic therapy for Bowen\u2019s Disease (squamous cell carcinoma in situ) current review and update","volume":"24","author":"O'Connell","year":"2018","journal-title":"Photodiagnosis Photodyn. Ther."},{"key":"10.1016\/j.bcp.2020.113931_b1000","series-title":"Color atlas and synopsis of clinical dermatology: common and serious diseases","author":"Fitzpatrick","year":"2001"},{"issue":"3","key":"10.1016\/j.bcp.2020.113931_b1005","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1021\/ml300002m","article-title":"NOSH-aspirin: a novel nitric oxide-hydrogen sulfide-releasing hybrid: a new class of anti-inflammatory pharmaceuticals","volume":"3","author":"Kodela","year":"2012","journal-title":"ACS Med. Chem. Lett."},{"issue":"11","key":"10.1016\/j.bcp.2020.113931_b1010","doi-asserted-by":"crossref","DOI":"10.1039\/c3md00185g","article-title":"Synthesis and biological activity of NOSH-naproxen (AVT-219) and NOSH-sulindac (AVT-18A) as potent anti-inflammatory agents with chemotherapeutic potential","volume":"4","author":"Kodela","year":"2013","journal-title":"MedChemComm"},{"key":"10.1016\/j.bcp.2020.113931_b1015","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.redox.2015.08.012","article-title":"NOSH-sulindac (AVT-18A) is a novel nitric oxide- and hydrogen sulfide-releasing hybrid that is gastrointestinal safe and has potent anti-inflammatory, analgesic, antipyretic, anti-platelet, and anti-cancer properties","volume":"6","author":"Kashfi","year":"2015","journal-title":"Redox Biol."},{"issue":"4","key":"10.1016\/j.bcp.2020.113931_b1020","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.bcp.2015.09.014","article-title":"NOSH-aspirin (NBS-1120), a novel nitric oxide- and hydrogen sulfide-releasing hybrid has enhanced chemo-preventive properties compared to aspirin, is gastrointestinal safe with all the classic therapeutic indications","volume":"98","author":"Kodela","year":"2015","journal-title":"Biochem. Pharmacol."},{"issue":"2","key":"10.1016\/j.bcp.2020.113931_b1025","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.224","article-title":"Gastrointestinal safety, chemotherapeutic potential, and classic pharmacological profile of NOSH-naproxen (AVT-219) a dual NO- and H2S-releasing hybrid","volume":"4","author":"Chattopadhyay","year":"2016","journal-title":"Pharmacol. Res. Perspect."},{"issue":"3","key":"10.1016\/j.bcp.2020.113931_b1030","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.bbrc.2012.02.051","article-title":"NOSH-aspirin (NBS-1120), a novel nitric oxide- and hydrogen sulfide-releasing hybrid is a potent inhibitor of colon cancer cell growth in vitro and in a xenograft mouse model","volume":"419","author":"Chattopadhyay","year":"2012","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"120","key":"10.1016\/j.bcp.2020.113931_b1035","first-page":"1","article-title":"Exploring the potential of nitric oxide- and hydrogen-sulfide releasing (NOSH) chimeras as novel priming agents against drought stress in Medicago sativa plants","volume":"10","author":"Antoniou","year":"2020","journal-title":"Biomolecules"},{"key":"10.1016\/j.bcp.2020.113931_b1040","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.redox.2017.11.020","article-title":"Novel H2S-NO hybrid molecule (ZYZ-803) promoted synergistic effects against heart failure","volume":"15","author":"Wu","year":"2018","journal-title":"Redox Biol."},{"key":"10.1016\/j.bcp.2020.113931_b1045","article-title":"ZYZ-803, a novel hydrogen sulfide-nitric oxide conjugated donor, promotes angiogenesis via cross-talk between STAT3 and CaMKII","author":"Xiong","year":"2019","journal-title":"Acta Pharmacol. Sin."},{"issue":"3","key":"10.1016\/j.bcp.2020.113931_b1050","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/sj.bjp.0707224","article-title":"Recent developments in nitric oxide donor drugs","volume":"151","author":"Miller","year":"2007","journal-title":"Br. J. Pharmacol."},{"issue":"10","key":"10.1016\/j.bcp.2020.113931_b1055","doi-asserted-by":"crossref","first-page":"4136","DOI":"10.1016\/j.actbio.2014.06.032","article-title":"Optimized polymeric film-based nitric oxide delivery inhibits bacterial growth in a mouse burn wound model","volume":"10","author":"Brisbois","year":"2014","journal-title":"Acta Biomater."},{"key":"10.1016\/j.bcp.2020.113931_b1060","doi-asserted-by":"crossref","first-page":"193","DOI":"10.3389\/fmicb.2012.00193","article-title":"Nitric oxide releasing nanoparticles for treatment of Candida albicans burn infections","volume":"3","author":"Macherla","year":"2012","journal-title":"Front. Microbiol."},{"issue":"10","key":"10.1016\/j.bcp.2020.113931_b1065","doi-asserted-by":"crossref","first-page":"3731","DOI":"10.1039\/c2cs15272j","article-title":"Nitric oxide release: part I. Macromolecular scaffolds","volume":"41","author":"Riccio","year":"2012","journal-title":"Chem. Soc. Rev."},{"issue":"12","key":"10.1016\/j.bcp.2020.113931_b1070","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1038\/s41565-019-0570-3","article-title":"Delivery of nitric oxide with a nanocarrier promotes tumour vessel normalization and potentiates anti-cancer therapies","volume":"14","author":"Sung","year":"2019","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.bcp.2020.113931_b1075","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.niox.2019.05.010","article-title":"New generation of nitric oxide-releasing porous materials: assessment of their potential to regulate biological functions","volume":"90","author":"Pinto","year":"2019","journal-title":"Nitric Oxide"},{"issue":"10","key":"10.1016\/j.bcp.2020.113931_b1080","doi-asserted-by":"crossref","first-page":"6539","DOI":"10.1166\/jnn.2019.17076","article-title":"Potential protective effect of nitric oxide-releasing nanofibers in hypoxia\/reoxygenation-induced cardiomyocyte injury","volume":"19","author":"Lee","year":"2019","journal-title":"J. Nanosci. Nanotechnol."},{"key":"10.1016\/j.bcp.2020.113931_b1085","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.jconrel.2015.02.007","article-title":"Delivering nitric oxide with nanoparticles","volume":"205","author":"Quinn","year":"2015","journal-title":"J. Control. Release"},{"issue":"4","key":"10.1016\/j.bcp.2020.113931_b1090","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1021\/bm050904i","article-title":"Synthesis and NMR characterization of new hyaluronan-based NO donors","volume":"7","author":"Di Meo","year":"2006","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.bcp.2020.113931_b1095","doi-asserted-by":"crossref","first-page":"23038","DOI":"10.1039\/c2jm34834a","article-title":"Enzymatically degradable nitric oxide releasingS-nitrosated dextranthiomers for biomedical applications","volume":"22","author":"Damodaran","year":"2012","journal-title":"J. Mater. Chem."},{"key":"10.1016\/j.bcp.2020.113931_b1100","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.actbio.2014.10.028","article-title":"S-Nitrosothiol-modified nitric oxide-releasing chitosan oligosaccharides as antibacterial agents","volume":"12","author":"Lu","year":"2015","journal-title":"Acta Biomater."},{"issue":"2","key":"10.1016\/j.bcp.2020.113931_b1105","doi-asserted-by":"crossref","first-page":"7449","DOI":"10.1039\/C4TB01340A","article-title":"Nitric oxide-releasing S-nitrosated derivatives of chitin and chitosan for biomedical applications","author":"Lutzke","year":"2014","journal-title":"J. Mater. Chem. B"},{"issue":"5","key":"10.1016\/j.bcp.2020.113931_b1110","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1016\/j.biomaterials.2013.11.015","article-title":"Nitric oxide-releasing chitosan oligosaccharides as antibacterial agents","volume":"35","author":"Lu","year":"2014","journal-title":"Biomaterials"},{"issue":"33","key":"10.1016\/j.bcp.2020.113931_b1115","doi-asserted-by":"crossref","first-page":"8450","DOI":"10.1016\/j.biomaterials.2013.07.045","article-title":"Polysaccharide-based biomaterials with on-demand nitric oxide releasing property regulated by enzyme catalysis","volume":"34","author":"Zhao","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.bcp.2020.113931_b1120","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.actbio.2014.11.032","article-title":"Electrospun nitric oxide releasing bandage with enhanced wound healing","volume":"13","author":"Lowe","year":"2015","journal-title":"Acta Biomater."},{"key":"10.1016\/j.bcp.2020.113931_b1125","doi-asserted-by":"crossref","unstructured":"R.V. Pinto, M.L. Pinto, Nanoporous Materials: New Generation of Nitric Oxide Donors, in: L.M.a.B. Bonavida (Ed.), Therapeutic Application of Nitric Oxide in Cancer and Inflammatory Disorders, Elsevier \u2013 Academic Press, San Diego, CA, USA, 2019, pp. 277\u2013305.","DOI":"10.1016\/B978-0-12-816545-4.00014-1"},{"issue":"5","key":"10.1016\/j.bcp.2020.113931_b1130","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1021\/jm950652b","article-title":"Nitric oxide-releasing polymers containing the [N(O)NO]- group","volume":"39","author":"Smith","year":"1996","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bcp.2020.113931_b1135","series-title":"Nitric oxide donors","first-page":"313","article-title":"Hydrogels for topical nitric oxide delivery","author":"Champeau","year":"2017"},{"issue":"25","key":"10.1016\/j.bcp.2020.113931_b1140","doi-asserted-by":"crossref","first-page":"8265","DOI":"10.1021\/ja060875z","article-title":"Dendrimers as a scaffold for nitric oxide release","volume":"128","author":"Stasko","year":"2006","journal-title":"J. Am. Chem. Soc."},{"issue":"18","key":"10.1016\/j.bcp.2020.113931_b1145","doi-asserted-by":"crossref","first-page":"4227","DOI":"10.1021\/cm201628z","article-title":"Structurally diverse nitric oxide-releasing poly(propylene imine) dendrimers","volume":"23","author":"Lu","year":"2011","journal-title":"Chem. Mater."},{"issue":"1","key":"10.1016\/j.bcp.2020.113931_b1150","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1021\/cm702526q","article-title":"Inorganic\/organic hybrid silica nanoparticles as a nitric oxide delivery scaffold","volume":"20","author":"Shin","year":"2008","journal-title":"Chem. Mater."},{"issue":"5","key":"10.1016\/j.bcp.2020.113931_b1155","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.addr.2012.08.015","article-title":"Surface engineering of inorganic nanoparticles for imaging and therapy","volume":"65","author":"Nam","year":"2013","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"9","key":"10.1016\/j.bcp.2020.113931_b1160","doi-asserted-by":"crossref","first-page":"4938","DOI":"10.1021\/la0633841","article-title":"Water-soluble nitric oxide-releasing gold nanoparticles","volume":"23","author":"Polizzi","year":"2007","journal-title":"Langmuir"},{"issue":"26","key":"10.1016\/j.bcp.2020.113931_b1165","doi-asserted-by":"crossref","first-page":"9362","DOI":"10.1021\/ja052027u","article-title":"Synthesis of nitric oxide-releasing gold nanoparticles","volume":"127","author":"Rothrock","year":"2005","journal-title":"J. Am. Chem. Soc."},{"issue":"9","key":"10.1016\/j.bcp.2020.113931_b1170","doi-asserted-by":"crossref","first-page":"3076","DOI":"10.1021\/jacs.5b12073","article-title":"Sunlight-triggered nanoparticle synergy: teamwork of reactive oxygen species and nitric oxide released from mesoporous organosilica with advanced antibacterial activity","volume":"138","author":"Gehring","year":"2016","journal-title":"J. Am. Chem. Soc."},{"issue":"6","key":"10.1016\/j.bcp.2020.113931_b1175","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1007\/s11274-019-2664-3","article-title":"Green synthesis of silver nanoparticles: effect of synthesis reaction parameters on antimicrobial activity","volume":"35","author":"Manosalva","year":"2019","journal-title":"World J. Microbiol. Biotechnol."},{"issue":"35","key":"10.1016\/j.bcp.2020.113931_b1180","doi-asserted-by":"crossref","first-page":"12879","DOI":"10.1021\/la302357h","article-title":"Nitric oxide delivery by core\/shell superparamagnetic nanoparticle vehicles with enhanced biocompatibility","volume":"28","author":"Zhang","year":"2012","journal-title":"Langmuir"},{"issue":"2","key":"10.1016\/j.bcp.2020.113931_b1185","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/j.msec.2012.10.027","article-title":"Nitric oxide donor superparamagnetic iron oxide nanoparticles","volume":"33","author":"Molina","year":"2013","journal-title":"Mater. Sci. Eng. C Mater. Biol. Appl."},{"issue":"2","key":"10.1016\/j.bcp.2020.113931_b1190","doi-asserted-by":"crossref","DOI":"10.3390\/nano9020138","article-title":"Polydopamine modified superparamagnetic iron oxide nanoparticles as multifunctional nanocarrier for targeted prostate cancer treatment","volume":"9","author":"Singh","year":"2019","journal-title":"Nanomaterials (Basel)"},{"issue":"1","key":"10.1016\/j.bcp.2020.113931_b1195","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1021\/ja074164s","article-title":"Quantum dot fluorescence quenching pathways with Cr(III) complexes. photosensitized NO production from trans-Cr(cyclam)(ONO)2+","volume":"130","author":"Neuman","year":"2008","journal-title":"J. Am. Chem. Soc."},{"issue":"48","key":"10.1016\/j.bcp.2020.113931_b1200","doi-asserted-by":"crossref","first-page":"15032","DOI":"10.1021\/la403028j","article-title":"Ag2S quantum dots conjugated chitosan nanospheres toward light-triggered nitric oxide release and near-infrared fluorescence imaging","volume":"29","author":"Tan","year":"2013","journal-title":"Langmuir"},{"issue":"7","key":"10.1016\/j.bcp.2020.113931_b1205","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/j.freeradbiomed.2004.06.019","article-title":"Nitric oxide-releasing hydrophobic polymers: preparation, characterization, and potential biomedical applications","volume":"37","author":"Reynolds","year":"2004","journal-title":"Free Radic. Biol. Med."},{"issue":"16","key":"10.1016\/j.bcp.2020.113931_b1210","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1002\/adhm.201600150","article-title":"Polydopamine hollow nanoparticle functionalized with N-diazeniumdiolates as a nitric oxide delivery carrier for antibacterial therapy","volume":"5","author":"Park","year":"2016","journal-title":"Adv. Healthc. Mater."},{"issue":"13","key":"10.1016\/j.bcp.2020.113931_b1215","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.201800155","article-title":"Nitric oxide-releasing macromolecular scaffolds for antibacterial applications","volume":"7","author":"Yang","year":"2018","journal-title":"Adv. Healthc. Mater."},{"issue":"12","key":"10.1016\/j.bcp.2020.113931_b1220","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1080\/17425247.2017.1285904","article-title":"Lipid-based carriers for controlled delivery of nitric oxide","volume":"14","author":"Elnaggar","year":"2017","journal-title":"Expert Opin. Drug Deliv."},{"issue":"10","key":"10.1016\/j.bcp.2020.113931_b1225","doi-asserted-by":"crossref","first-page":"3569","DOI":"10.1021\/acs.molpharmaceut.5b00248","article-title":"Encapsulation of N-diazeniumdiolates within liposomes for enhanced nitric oxide donor stability and delivery","volume":"12","author":"Suchyta","year":"2015","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.bcp.2020.113931_b1230","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.cis.2017.05.020","article-title":"Liposomes and lipid bilayers in biosensors","volume":"249","author":"Mazur","year":"2017","journal-title":"Adv. Colloid Interface Sci."},{"issue":"19","key":"10.1016\/j.bcp.2020.113931_b1235","doi-asserted-by":"crossref","first-page":"10938","DOI":"10.1021\/acs.chemrev.5b00046","article-title":"New developments in liposomal drug delivery","volume":"115","author":"Pattni","year":"2015","journal-title":"Chem. Rev."},{"issue":"84","key":"10.1016\/j.bcp.2020.113931_b1240","doi-asserted-by":"crossref","first-page":"53236","DOI":"10.1039\/C7RA09899E","article-title":"Anticancer potency of nitric oxide-releasing liposomes","volume":"7","author":"Suchyta","year":"2017","journal-title":"RSC Adv."},{"issue":"4","key":"10.1016\/j.bcp.2020.113931_b1245","doi-asserted-by":"crossref","first-page":"298","DOI":"10.2174\/1568026615666150108122918","article-title":"Nitric oxide releasing nanomaterials for cancer treatment: current status and perspectives","volume":"15","author":"Seabra","year":"2015","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.bcp.2020.113931_b1250","doi-asserted-by":"crossref","unstructured":"R.E. Morris, P.S. Wheatley, Gas storage in nanoporous materials, Angew. Chem. (Int. Ed. English) 47(27) (2008) 4966\u20134981.","DOI":"10.1002\/anie.200703934"},{"key":"10.1016\/j.bcp.2020.113931_b1255","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.actbio.2017.01.039","article-title":"Vitamin B3 metal-organic frameworks as potential delivery vehicles for therapeutic nitric oxide","volume":"51","author":"Pinto","year":"2017","journal-title":"Acta Biomater."},{"issue":"16","key":"10.1016\/j.bcp.2020.113931_b1260","doi-asserted-by":"crossref","first-page":"6396","DOI":"10.1021\/ja200663e","article-title":"Slow release of NO by microporous titanosilicate ETS-4","volume":"133","author":"Pinto","year":"2011","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.bcp.2020.113931_b1265","series-title":"Molecular Sieves: From Basic Research to Industrial Applications","first-page":"2033","article-title":"Zeolites for storage and delivery of nitric oxide in human physiology","author":"Wheatley","year":"2005"},{"issue":"2","key":"10.1016\/j.bcp.2020.113931_b1270","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/sj.jid.5701096","article-title":"Topically applied nitric oxide induces T-lymphocyte infiltration in human skin, but minimal inflammation","volume":"128","author":"Mowbray","year":"2008","journal-title":"J. Invest. Dermatol."},{"issue":"Pt 2","key":"10.1016\/j.bcp.2020.113931_b1275","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1099\/jmm.0.067322-0","article-title":"Antimicrobial efficacy and wound-healing property of a topical ointment containing nitric-oxide-loaded zeolites","volume":"63","author":"Neidrauer","year":"2014","journal-title":"J. Med. Microbiol."},{"issue":"4","key":"10.1016\/j.bcp.2020.113931_b1280","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1016\/j.actbio.2009.10.038","article-title":"NO-loaded Zn(2+)-exchanged zeolite materials: a potential bifunctional anti-bacterial strategy","volume":"6","author":"Fox","year":"2010","journal-title":"Acta Biomater."},{"issue":"3","key":"10.1016\/j.bcp.2020.113931_b1285","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.clay.2010.01.007","article-title":"Current challenges in clay minerals for drug delivery","volume":"48","author":"Viseras","year":"2010","journal-title":"Appl. Clay Sci."},{"issue":"1","key":"10.1016\/j.bcp.2020.113931_b1290","doi-asserted-by":"crossref","first-page":"3287","DOI":"10.1039\/c3tb20535e","article-title":"Clay based materials for storage and therapeutic release of nitric oxide","author":"Fernandes","year":"2013","journal-title":"J. Mater. Chem. B"},{"issue":"17","key":"10.1016\/j.bcp.2020.113931_b1295","doi-asserted-by":"crossref","first-page":"3556","DOI":"10.1039\/C4TB01913J","article-title":"L-Histidine-based organoclays for the storage and release of therapeutic nitric oxide","volume":"3","author":"Fernandes","year":"2015","journal-title":"J. Mater. Chem. B"},{"issue":"47","key":"10.1016\/j.bcp.2020.113931_b1300","doi-asserted-by":"crossref","first-page":"41195","DOI":"10.1039\/C6RA05794B","article-title":"Synthetic cobalt clays for the storage and slow release of therapeutic nitric oxide","volume":"6","author":"Fernandes","year":"2016","journal-title":"RSC Adv."},{"issue":"11","key":"10.1016\/j.bcp.2020.113931_b1305","doi-asserted-by":"crossref","first-page":"3104","DOI":"10.1039\/C7CS90049J","article-title":"The new age of MOFs and of their porous-related solids","volume":"46","author":"Maurin","year":"2017","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.bcp.2020.113931_b1310","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.colsurfb.2015.04.007","article-title":"Combined nitric oxide-releasing poly(vinyl alcohol) film\/F127 hydrogel for accelerating wound healing","volume":"130","author":"Schanuel","year":"2015","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.bcp.2020.113931_b1315","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.colsurfb.2013.10.036","article-title":"Nitric oxide-releasing poly(vinyl alcohol) film for increasing dermal vasodilation","volume":"116","author":"Marcilli","year":"2014","journal-title":"Colloids Surf B Biointerfaces"},{"issue":"11","key":"10.1016\/j.bcp.2020.113931_b1320","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1007\/s10856-009-3795-0","article-title":"Characterization of pHEMA-based hydrogels that exhibit light-induced bactericidal effect via release of NO","volume":"20","author":"Halpenny","year":"2009","journal-title":"J. Mater. Sci. \u2013 Mater. Med."},{"issue":"80","key":"10.1016\/j.bcp.2020.113931_b1325","doi-asserted-by":"crossref","first-page":"9173","DOI":"10.1039\/c3cc45666h","article-title":"Enzyme-controllable delivery of nitric oxide from a molecular hydrogel","volume":"49","author":"Gao","year":"2013","journal-title":"Chem. Commun. (Camb.)"},{"issue":"2","key":"10.1016\/j.bcp.2020.113931_b1330","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s00424-008-0519-0","article-title":"H(2)S and HS(\u2013) donor NaHS releases nitric oxide from nitrosothiols, metal nitrosyl complex, brain homogenate and murine L1210 leukaemia cells","volume":"457","author":"Ondrias","year":"2008","journal-title":"Pflugers Arch."},{"key":"10.1016\/j.bcp.2020.113931_b1335","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1509277112","article-title":"Key bioactive reaction products of the NO\/H2S interaction are S\/N-hybrid species, polysulfides, and nitroxyl","author":"Cortese-Krott","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"34","key":"10.1016\/j.bcp.2020.113931_b1340","doi-asserted-by":"crossref","first-page":"E4651","DOI":"10.1073\/pnas.1509277112","article-title":"Key bioactive reaction products of the NO\/H2S interaction are S\/N-hybrid species, polysulfides, and nitroxyl","volume":"112","author":"Cortese-Krott","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U.S.A."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295220301593?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295220301593?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T13:14:44Z","timestamp":1757769284000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295220301593"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":268,"alternative-id":["S0006295220301593"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2020.113931","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The evolving landscape for cellular nitric oxide and hydrogen sulfide delivery systems: A new era of customized medications","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2020.113931","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"113931"}}